Literature DB >> 454263

Stargardt's disease and fundus flavimaculatus.

K G Noble, R E Carr.   

Abstract

A study of 67 patients with a diagnosis of Stargardt's disease (juvenile macular degeneration) or fundus flavimaculatus showed that, apart from the ophthalmoscopic appearance, there is no clear distinction between these two disorders. The disease is an autosomal recessive macular degeneration that is bilateral and symmetrical in appearance, with diminished central vision as the hallmark symptom. The onset of symptoms usually occurred in the first or second decade, but a substantial number of patients were asymptomatic until the fourth or fifth decade. Psychophysical and electrophysiologic tests indicated that this is a localized and not a generalized retinal dystrophy. While the initial vision in the better eye was 6/12 (20/40) or better in one third of the patients, follow-up studies showed progression to levels between 6/30 (20/100) and 6/60 (20/400).

Entities:  

Mesh:

Year:  1979        PMID: 454263     DOI: 10.1001/archopht.1979.01020020023005

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  44 in total

1.  Color vision in Stargardt's disease.

Authors:  M Mäntyjärvi; K Tuppurainen
Journal:  Int Ophthalmol       Date:  1992-11       Impact factor: 2.031

2.  The electroretinogram in Stargardt's disease and fundus flavimaculatus.

Authors:  P Lachapelle; J M Little; M S Roy
Journal:  Doc Ophthalmol       Date:  1989-12       Impact factor: 2.379

3.  Inhibition of the visual cycle by A2E through direct interaction with RPE65 and implications in Stargardt disease.

Authors:  Gennadiy Moiseyev; Olga Nikolaeva; Ying Chen; Krysten Farjo; Yusuke Takahashi; Jian-xing Ma
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

4.  Sorting out co-occurrence of rare monogenic retinopathies: Stargardt disease co-existing with congenital stationary night blindness.

Authors:  Nancy Huynh; Brett G Jeffrey; Amy Turriff; Paul A Sieving; Catherine A Cukras
Journal:  Ophthalmic Genet       Date:  2014-01-07       Impact factor: 1.803

5.  Multifocal electroretinography in patients with Stargardt's macular dystrophy.

Authors:  U Kretschmann; M W Seeliger; K Ruether; T Usui; E Apfelstedt-Sylla; E Zrenner
Journal:  Br J Ophthalmol       Date:  1998-03       Impact factor: 4.638

Review 6.  The role of the photoreceptor ABC transporter ABCA4 in lipid transport and Stargardt macular degeneration.

Authors:  Robert S Molday; Ming Zhong; Faraz Quazi
Journal:  Biochim Biophys Acta       Date:  2009-02-20

7.  Electrophysiological analysis of Stargardt's disease fundus flavimaculatus group.

Authors:  K Wakabayashi; D Yonemura; K Kawasaki
Journal:  Doc Ophthalmol       Date:  1985-08-30       Impact factor: 2.379

8.  Fundus flavimaculatus: polymorphic retinal change in siblings.

Authors:  Y Isashiki; N Ohba
Journal:  Br J Ophthalmol       Date:  1985-07       Impact factor: 4.638

9.  Genotype/Phenotype analysis of a photoreceptor-specific ATP-binding cassette transporter gene, ABCR, in Stargardt disease.

Authors:  R A Lewis; N F Shroyer; N Singh; R Allikmets; A Hutchinson; Y Li; J R Lupski; M Leppert; M Dean
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

10.  Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration.

Authors:  Francesca Simonelli; Albert M Maguire; Francesco Testa; Eric A Pierce; Federico Mingozzi; Jeannette L Bennicelli; Settimio Rossi; Kathleen Marshall; Sandro Banfi; Enrico M Surace; Junwei Sun; T Michael Redmond; Xiaosong Zhu; Kenneth S Shindler; Gui-Shuang Ying; Carmela Ziviello; Carmela Acerra; J Fraser Wright; Jennifer Wellman McDonnell; Katherine A High; Jean Bennett; Alberto Auricchio
Journal:  Mol Ther       Date:  2009-12-01       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.